ANI Pharmaceuticals, Inc. (BST:BSFA)

ANI Pharmaceuticals Statistics

Total Valuation

BST:BSFA has a market cap or net worth of EUR 1.63 billion. The enterprise value is 1.94 billion.

Market Cap	1.63B
Enterprise Value	1.94B

Important Dates

The last earnings date was Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	20.70M
Shares Outstanding	n/a
Shares Change (YoY)	+6.95%
Shares Change (QoQ)	+3.87%
Owned by Insiders (%)	7.90%
Owned by Institutions (%)	100.16%
Float	18.62M

Valuation Ratios

The trailing PE ratio is 49.10 and the forward PE ratio is 11.51.

PE Ratio	49.10
Forward PE	11.51
PS Ratio	2.32
PB Ratio	3.79
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	58.46
EV / Sales	2.72
EV / EBITDA	15.13
EV / EBIT	41.89
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.58, with a Debt / Equity ratio of 1.25.

Current Ratio	2.58
Quick Ratio	1.94
Debt / Equity	1.25
Debt / EBITDA	4.25
Debt / FCF	n/a
Interest Coverage	1.44

Financial Efficiency

Return on equity (ROE) is 8.66% and return on invested capital (ROIC) is 3.05%.

Return on Equity (ROE)	8.66%
Return on Assets (ROA)	2.49%
Return on Invested Capital (ROIC)	3.05%
Return on Capital Employed (ROCE)	4.72%
Revenue Per Employee	785,674
Profits Per Employee	37,064
Employee Count	897
Asset Turnover	0.61
Inventory Turnover	2.20

Taxes

In the past 12 months, BST:BSFA has paid 8.51 million in taxes.

Income Tax	8.51M
Effective Tax Rate	19.74%

Stock Price Statistics

The stock price has increased by +44.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+44.86%
50-Day Moving Average	79.00
200-Day Moving Average	63.31
Relative Strength Index (RSI)	45.66
Average Volume (20 Days)	3

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.10

Income Statement

In the last 12 months, BST:BSFA had revenue of EUR 704.75 million and earned 33.25 million in profits. Earnings per share was 1.42.

Revenue	704.75M
Gross Profit	428.14M
Operating Income	45.79M
Pretax Income	43.08M
Net Income	33.25M
EBITDA	124.58M
EBIT	45.79M
Earnings Per Share (EPS)	1.42

Balance Sheet

The company has 231.37 million in cash and 538.30 million in debt, giving a net cash position of -306.92 million.

Cash & Cash Equivalents	231.37M
Total Debt	538.30M
Net Cash	-306.92M
Net Cash Per Share	n/a
Equity (Book Value)	431.11M
Book Value Per Share	21.48
Working Capital	364.65M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 60.75%, with operating and profit margins of 6.50% and 4.91%.

Gross Margin	60.75%
Operating Margin	6.50%
Pretax Margin	6.11%
Profit Margin	4.91%
EBITDA Margin	17.68%
EBIT Margin	6.50%
FCF Margin	n/a

Dividends & Yields

BST:BSFA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.95%
Shareholder Yield	-6.95%
Earnings Yield	2.04%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BST:BSFA has an Altman Z-Score of 1.9 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.9
Piotroski F-Score	5